The Harms of Urine Drug Screening for Isolated Marijuana Use on Labor and Delivery Units

Rivlin, Katherine MD, MSc

Section Chief, Family Planning, University of Chicago

Financial Disclosure: Dr. Rebecca H. Allen (editor) reports that she receives grant/research support from Bayer and is a consultant for Cadence. All of the relevant financial relationships listed for this individual have been mitigated. None of the remaining planners or authors for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

OB/GYN Clinical Alert 39(8):p 57-59, December 2022.

SYNOPSIS: Isolated marijuana use, when used as an indication for urine drug screening during the labor and delivery period, poorly predicts concomitant use of other nonprescribed substances. However, use of the screening brings real risk of inequitable harm.

SOURCE: Rubin A, Zhong L, Nacke L, et al. Urine drug screening for isolated marijuana use in labor and delivery units. Obstet Gynecol 2022; Sep 9. doi: 10.1097/AOG.0000000000004930. [Online ahead of print].